anders2211, Would you like to respond to any of the points in my post? I wouldn't if I were you, lol.
Perhaps the 21x is the multiplier the market gave Optune-- a device that doesn't work and has to be worn 20+ hours a day, minces heads to sausage meat, and its approval was based on bogus data. But yet DCVax-L, in your opinion, with superb data, has very high uncertainty, a 4x multiplier and that no one will partner with it until after approval. That's your position...lol.
Again, as stated previously, my enthusiasm for, and dreams of, NWBO are based on 10 years+ of published/PR interim (not muddy) data validated by 69 renown experts in the field.
---------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- With regard to my expectations of exceptional returns, here's Abeta’s market cap chart for the details:
I know on what why enthusiasm is based and can support my positions.
AI
